ATE253356T1 - N-formyl hydroxylamin derivate als antibakterielle mittel - Google Patents

N-formyl hydroxylamin derivate als antibakterielle mittel

Info

Publication number
ATE253356T1
ATE253356T1 AT99959596T AT99959596T ATE253356T1 AT E253356 T1 ATE253356 T1 AT E253356T1 AT 99959596 T AT99959596 T AT 99959596T AT 99959596 T AT99959596 T AT 99959596T AT E253356 T1 ATE253356 T1 AT E253356T1
Authority
AT
Austria
Prior art keywords
alkyl
group
antibacterial agents
represents hydrogen
alk
Prior art date
Application number
AT99959596T
Other languages
English (en)
Inventor
Michael George Hunter
Raymond Paul Beckett
Martin John Clements
Mark Whittaker
Original Assignee
British Biotech Pharm
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by British Biotech Pharm filed Critical British Biotech Pharm
Application granted granted Critical
Publication of ATE253356T1 publication Critical patent/ATE253356T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/351—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom not condensed with another ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/223—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of alpha-aminoacids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pyrane Compounds (AREA)
AT99959596T 1998-12-16 1999-12-13 N-formyl hydroxylamin derivate als antibakterielle mittel ATE253356T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9827805.4A GB9827805D0 (en) 1998-12-16 1998-12-16 Antibacterial agents
PCT/GB1999/004217 WO2000035440A1 (en) 1998-12-16 1999-12-13 N-formyl hydroxylamine derivatives as antibacterial agents

Publications (1)

Publication Number Publication Date
ATE253356T1 true ATE253356T1 (de) 2003-11-15

Family

ID=10844420

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99959596T ATE253356T1 (de) 1998-12-16 1999-12-13 N-formyl hydroxylamin derivate als antibakterielle mittel

Country Status (8)

Country Link
US (1) US6476067B1 (de)
EP (1) EP1140058B1 (de)
JP (1) JP2002532417A (de)
AT (1) ATE253356T1 (de)
AU (1) AU1672900A (de)
DE (1) DE69912639T2 (de)
GB (1) GB9827805D0 (de)
WO (1) WO2000035440A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7323596B2 (en) 2000-12-21 2008-01-29 De Novo Pharmaceuticals Ltd. Antimicrobial agents
UY27192A1 (es) * 2001-03-01 2002-09-30 Smithkline Beecham Corp Inhibidores de peptido-deformilasa
UY27813A1 (es) 2002-05-31 2003-12-31 Smithkline Beecham Corp Inhibidores de la peptido-desformilasa
US7442793B2 (en) 2002-12-11 2008-10-28 Smithkline Beecham Corporation Peptide deformylase inhibitors
KR100774728B1 (ko) 2006-05-25 2007-11-08 일동제약주식회사 펩티드 데포르밀라제 저해제로서 신규의 엔-포르밀히드록실아민 유도체 및 그 제조방법
FR3098217B1 (fr) * 2019-07-05 2023-04-21 Pharmaleads N-Formylhydroxylamines en tant qu’inhibiteurs mixtes de l’aminopeptidase N (APN) et de la néprilysine (NEP)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2518088B1 (fr) * 1981-12-16 1987-11-27 Roques Bernard Nouveaux derives d'aminoacides, et leur application therapeutique
GB9514867D0 (en) 1995-07-20 1995-09-20 British Biotech Pharm Metalloproteinase inhibitors
WO1997038705A1 (en) * 1996-04-12 1997-10-23 Bristol-Myers Squibb Company N-formyl hydroxylamine containing compounds useful as ace inhibitors and/or nep inhibitors

Also Published As

Publication number Publication date
WO2000035440A1 (en) 2000-06-22
EP1140058A1 (de) 2001-10-10
DE69912639T2 (de) 2004-09-16
DE69912639D1 (de) 2003-12-11
GB9827805D0 (en) 1999-02-10
AU1672900A (en) 2000-07-03
JP2002532417A (ja) 2002-10-02
US6476067B1 (en) 2002-11-05
EP1140058B1 (de) 2003-11-05

Similar Documents

Publication Publication Date Title
WO1999039704A8 (en) Antibacterial agents
NZ507560A (en) Hydroxamic acid derivatives as antibacterials
DK0641355T3 (da) Anvendelse af sulfamatderivater som steroid-sulfatase-inhibitorer
BR9908275A (pt) Inibidores de enzimas fosfolipase
BR0207025A (pt) Derivado de isoxazolina e herbicida contendo o mesmo como o ingrediente ativo
DE69920496D1 (de) Piperidin- und pyrrolidin-derivate enthaltend ein stickstoffoxid donor zur behandlung von stress
BR9910900A (pt) Derivados isotiazol úteis como agentes anticancerìgenos
DK0861228T3 (da) Lipopolyaminer som transfektionsmidler samt deres farmaceutiske anvendelser
BRPI0315188B8 (pt) composto e composição farmacêutica
DK0583485T3 (da) Ethanolaminderivater med sympathomimetiske og anti-pollakisuria-virkninger
DK0705257T3 (da) Aminosyrederivater som NO-syntaseinhibitorer
AP1555A (en) Derivatives of isosorbid mononitrate, utilization as vasodilator agents with reduced tolerance
DE69912639D1 (de) N-formyl hydroxylamin derivate als antibakterielle mittel
ATE44748T1 (de) 4-substituierte 6-alkylidene-androsten-3,17-dion- derivate und verfahren zu ihrer herstellung.
DK1362844T3 (da) Benzylaminanalog
BR0006299A (pt) Derivados da 4-oxo-2-ureìdo-1,4,5,6-tetra-hidro-pirimidina
AU5879798A (en) Agents inhibiting progress of pterygium and postoperative recurrence of the same
WO2003022797A1 (en) Carba-sugar amine derivatives and treatments for disorder of glycolipid metabolism containing the same as the active ingredient
AU2118900A (en) Antibacterial hydroxamic acid derivatives
MX15635A (es) Amidas de acidos ciclometilen-1,2-dicarboxilicos y el procedimiento para su preparacion.
EP0712411A1 (de) Antiparasitiches mittel
DE60003671D1 (de) Halo-derivate von 9-deoxo-9a-aza-9a-homerythromycin a
AU4788896A (en) Imidazole derivative

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties